Amsacrine lactate
Based on 8 publication(s) in Google Scholar
Amsacrine lactate (m-AMSA lactate) is a Topoisomerase II inhibitor. Amsacrine lactate intercalates into DNA. Amsacrine lactate induces Ca2+-mediated inactivation of ERK, and also downregulates AKT, promoting MCL1 downregulation mediated by GSK3β via reducing the phosphorylation level of GSK3β. Amsacrine lactate induces Apoptosis by activating Caspase-9 and Caspase-3. Amsacrine lactate blocks HERG potassium channels in the open/inactivated state. Amsacrine lactate induces chromosomal aberrations and sister chromatid exchanges, and inhibits the synthesis of RNA and DNA. Amsacrine lactate exhibits anti-leukemic activity. Amsacrine lactate causes cardiac repolarization disorders, QT interval prolongation, ventricular arrhythmias, and increases the risk of sudden cardiac death. Amsacrine lactate can be used in research related to acute myeloid leukemia, lymphoma and progressive malignancies.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 80277-11-8
- 分子式: C24H25N3O6S
- 分子量:483.54
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
MedChemExpress(MCE)の使用を引用している文献 Amsacrine lactate
More- Cell Metab. 2022 Mar 1;34(3):424-440.e7. [Abstract]
- J Adv Res. 2024 Apr:58:117-128. [Abstract]
- ACS Environ Au. 2025 Aug 5;5(6):573-582. [Abstract]
- Anal Chem. 2025 Jun 3;97(21):11099-11109. [Abstract]
- J Mol Med (Berl). 2019 Aug;97(8):1183-1193. [Abstract]
- Nucleic Acid Ther. 2023 Aug;33(4):248-264. [Abstract]
- University of Colorado Denver. 2024.
- bioRxiv. September 29, 2021.
Topoisomerase アイソフォーム固有の製品をすべて表示
MoreDNA/RNA Synthesis アイソフォーム固有の製品をすべて表示
MoreCaspase アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
Topoisomerase-2 |
GSK-3β |
MCL1 |
Caspase-9 |
Caspase-3 |
体外実験
Amsacrine (1 μM; 4 h) lactate induces downregulation of phosphorylated and total AKT in acute myeloid leukemia U937 cells via a proteasome-dependent pathway, and this effect is abolished by pretreatment with MG132 (5 μM; 1 h)[1].
Amsacrine (0.01-100 μM) lactate potently blocks wild-type HERG potassium channels heterologously expressed in Xenopus oocytes, with an IC50 of 2.0 μM, and exhibits partial reversibility after washout[2].
The inhibitory effect of Amsacrine (10 μM) lactate on HERG potassium channels heterologously expressed in Xenopus oocytes is attenuated in the HERGY652A mutant, and completely abolished in the HERGF656A and HERGY652A/F656A mutants, indicating that this effect depends on the aromatic residues in the S6 segment of the pore region[2].
Lactate salt of Amsacrine (at different concentrations; perfused to achieve steady-state block) potently blocks wild-type HERG potassium channels stably expressed in 293 cells, with an IC50 of 209.4 nM[2].
Amsacrine lactate induces chromosome aberrations, sister chromatid exchanges and micronucleus formation in vitro in a variety of mammalian cells[3].
Amsacrine (0.005-0.25 μg/mL) lactate induces a dose-dependent increase in chromosome aberrations and sister chromatid exchanges in cultured normal peripheral blood lymphocytes in vitro, with 0.005 μg/mL increasing SCE by 1.5-fold and 0.25 μg/mL increasing SCE by 12-fold[4].
Amsacrine (5.0 μg/mL; 36 h) lactate inhibits 80% of RNA synthesis and 60% of DNA synthesis in cultured human peripheral blood lymphocytes in vitro, and exerts no significant effect on protein synthesis after 36 h of incubation[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:U937 cells
-
Concentration:1 μM (amsacrine treatment); 5 μM (MG132 pretreatment)
-
Incubation Time:4 h (amsacrine treatment); 1 h (MG132 pretreatment)
-
Result:Induced down-regulation of phosphorylated and total AKT protein levels.
Increased AKT protein turnover.
Was completely blocked by MG132 pretreatment, which restored phosphorylated and total AKT protein levels to near control levels.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:white Swiss albino (male, 10-14 weeks old, 25-30 g)[3]
-
Dosage:0.5 mg/kg; 1.5 mg/kg; 4.5 mg/kg; 6 mg/kg; 9 mg/kg; 12 mg/kg
-
Administration:i.p.; single dose
-
Result:Did not significantly increase micronucleated polychromatic erythrocyte (%MNPCE) frequency compared to controls at 0.5, 1.5, 4.5, and 6 mg/kg doses at 24 hours post-treatment.
Caused a %MNPCE of 0.58 and reduced %PCE to 43.20 at 9 mg/kg dose at 24 hours post-treatment (P < 0.05).
Caused a %MNPCE of 0.92 and reduced %PCE to 39.80 at 12 mg/kg dose at 24 hours post-treatment (P < 0.01).
Did not significantly increase %MNPCE frequency compared to controls at 0.5, 1.5, 4.5, and 6 mg/kg doses at 30 hours post-treatment.
Caused a %MNPCE of 0.68 and reduced %PCE to 42.60 at 9 mg/kg dose at 30 hours post-treatment (P < 0.05).
Caused a %MNPCE of 0.98 and reduced %PCE to 37.00 at 12 mg/kg dose at 30 hours post-treatment (P < 0.01).
Showed 69.38% of micronuclei were centromere-negative (clastogenic effect), with 24.38% having no signal and 45% having only telomere signals, and 30.62% were centromere-positive (aneugenic effect) at 12 mg/kg dose.
化学情報
-
CAS 番号 80277-11-8
-
分子量 483.54
-
分子式 C24H25N3O6S
-
SMILES
O=C(C(C)O)O.O=S(NC1=CC=C(C(OC)=C1)NC2=C3C=CC=CC3=NC4=C2C=CC=C4)(C)=O
-
別名
m-AMSA lactate; Acridinyl anisidide lactate
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (8)
-
Journal Impact Factor
-
Most Recent
-
Cell Metab
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. [Abstract]2022 Mar 1;34(3):424-440.e7. PMID: 35150639 -
J Adv Res
Postantibiotic leukocyte enhancement-mediated reduction of intracellular bacteria by macrophages. [Abstract]2024 Apr:58:117-128. PMID: 37290606 -
ACS Environ Au
Machine Learning-Assisted Recognition of Environmental Sulfur-Containing Chemicals in Nontargeted Mass Spectrometry Analysis of Inadequate Mass Resolution. [Abstract]2025 Aug 5;5(6):573-582. PMID: 41277996 -
Anal Chem
Exposome-Scale Investigation of Cl-/Br-Containing Chemicals Using High-Resolution Mass Spectrometry, Multistage Machine Learning, and Cloud Computing. [Abstract]2025 Jun 3;97(21):11099-11109. PMID: 40401576 -
J Mol Med (Berl)
2019 Aug;97(8):1183-1193. PMID: 31201471 -
Nucleic Acid Ther
Mammalian Target of Rapamycin Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells. [Abstract]2023 Aug;33(4):248-264. PMID: 37389884 -
-
純度とドキュメンテーション
参考文献
[1]. Lee YC, et al. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Apoptosis : an international journal on programmed cell death. 2017 Mar;22(3):406-420. [Content Brief]
[2]. Thomas D, et al. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action. British journal of pharmacology. 2004 Jun;142(3):485-94. [Content Brief]
[3]. Attia SM. Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells. Journal of applied toxicology : JAT. 2013 Jun;33(6):426-33. [Content Brief]
[4]. Kao-Shan CS, et al. Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro. Cancer treatment reports. 1984;68(7-8):989-97. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Amsacrine
- 80277-11-8
- m-AMSA
- Acridinyl anisidide
- Topoisomerase
- DNA/RNA Synthesis
- DNA Alkylator/Crosslinker
- ERK
- Akt
- GSK-3
- Bcl-2 Family
- Caspase
- Apoptosis
- Potassium Channel
- Extracellular signal regulated kinases
- PKB
- Protein kinase B
- Glycogen synthase kinase-3
- Glycogen synthase kinase 3
- KcsA
- AKT
- caspase-9
- GSK3β
- Pin1
- caspase-3
- topoisomerase II
- DNA
- MCL1
- HERG potassium channels
- Inhibitor
- inhibitor
- inhibit